Transactions
Tillotts Pharma acquired by Zeria Pharmaceutical
Sep. 2009
Client: Tillotts is a leading gastroenterology products pharmaceutical company - Its lead product is Asacol, which it markets under exclusive rights in 44 countries
Role: Edgemont Partners and IMI Consulting acted as exclusive financial advisors to Tillotts Pharma in its sale to Zeria Pharmaceutical
Location: Ziefen, Switzerland
Sector: Pharmaceutical Services
Lead Banker: David Blume
acquired by
